Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Vaxart Inc (VXRT)

Vaxart Inc (VXRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 175,671
  • Shares Outstanding, K 176,838
  • Annual Sales, $ 7,380 K
  • Annual Income, $ -82,470 K
  • 60-Month Beta 0.72
  • Price/Sales 21.49
  • Price/Cash Flow N/A
  • Price/Book 2.85
Trade VXRT with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.53
  • Most Recent Earnings $-0.14 on 05/13/24
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 184.32% ( +50.29%)
  • Historical Volatility 107.01%
  • IV Percentile 25%
  • IV Rank 10.95%
  • IV High 1,350.97% on 01/12/24
  • IV Low 40.88% on 05/09/24
  • Put/Call Vol Ratio 0.18
  • Today's Volume 212
  • Volume Avg (30-Day) 349
  • Put/Call OI Ratio 0.03
  • Today's Open Interest 25,080
  • Open Int (30-Day) 24,139

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.16
  • Number of Estimates 2
  • High Estimate -0.15
  • Low Estimate -0.16
  • Prior Year -0.16
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.6331 +42.06%
on 04/25/24
1.0600 -15.15%
on 05/16/24
+0.1540 (+20.66%)
since 04/23/24
3-Month
0.6331 +42.06%
on 04/25/24
1.4100 -36.21%
on 03/28/24
-0.3706 (-29.18%)
since 02/23/24
52-Week
0.5300 +69.70%
on 12/29/23
1.5400 -41.60%
on 02/22/24
-0.5006 (-35.76%)
since 05/23/23

Most Recent Stories

More News
Stock Index Futures Muted as Weak China Trade Data Weighs on Sentiment

June S&P 500 futures (ESM23) are up +0.14%, and June Nasdaq 100 E-Mini futures (NQM23) are up +0.09% this morning as weak trade data from China stoked investor concerns over the strength of global demand....

ESM23 : 4,453.35s (+0.61%)
NQM23 : 15,316.61s (+0.85%)
PACW : 7.54 (-2.71%)
WAL : 62.50 (-2.89%)
INTC : 30.08 (-4.26%)
AMD : 160.43 (-3.08%)
COIN : 218.86 (-5.46%)
ITX.E.DX : 44.200 (+1.26%)
YEXT : 5.15 (-3.56%)
GDYN : 10.17 (+0.79%)
VXRT : 0.8994 (-9.46%)
DAWN : 13.87 (-5.13%)
These 2 Stocks Carry a Lot of Risk, but Their Upside Is Huge

Novavax and Vaxart have each dropped more than 80% over the past year.

PFE : 28.69 (-3.07%)
NVAX : 15.15 (-3.50%)
VXRT : 0.8994 (-9.46%)
Profound Medical (PROF) Surges 5.1%: Is This an Indication of Further Gains?

Profound Medical (PROF) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down...

PROF : 7.42 (-6.08%)
VXRT : 0.8994 (-9.46%)
VAXART, INC. (VXRT) Reports Q3 Loss, Misses Revenue Estimates

VAXART, INC. (VXRT) delivered earnings and revenue surprises of 4.17% and 100%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

VXRT : 0.8994 (-9.46%)
XBIO : 3.84 (-3.12%)
VAXART, INC. (VXRT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

VAXART, INC. (VXRT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

VXRT : 0.8994 (-9.46%)
PCRX : 30.32 (-1.30%)
3 Supercharged Growth Stocks With 257% to 379% Upside, According to Wall Street

Select analysts believe these industry game changers can skyrocket over the next year.

NIO : 4.80 (-8.40%)
VXRT : 0.8994 (-9.46%)
PLUG : 3.08 (-9.82%)
2 Struggling Stocks to Avoid Right Now

Investors looking for bargains should look elsewhere.

CGC : 9.11 (-3.19%)
VXRT : 0.8994 (-9.46%)
VAXART, INC. (VXRT) Reports Q2 Loss, Lags Revenue Estimates

VAXART, INC. (VXRT) delivered earnings and revenue surprises of -9.52% and 100%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

VXRT : 0.8994 (-9.46%)
CVSI : 0.0510 (-7.27%)
Vaxart Provides Business Update and Reports Second Quarter 2022 Financial Results

Top-line data from COVID-19 Phase II study expected in the third quarter of 2022 Vaxart initiates work on vaccine candidates that directly target new...

VXRT : 0.8994 (-9.46%)
Vaxart Appoints W. Mark Watson to its Board of Directors

Non-executive director to bring extensive life science industry and finance experience SOUTH SAN FRANCISCO, Calif., Aug. 08, 2022 (GLOBE NEWSWIRE) --...

VXRT : 0.8994 (-9.46%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Vaxart, Inc. is a clinical-stage company developing a range of oral recombinant vaccines based on its proprietary delivery platform. The company's vaccines are administered using convenient room temperature-stable tablets that can be stored and shipped without refrigeration and eliminate risk of needle-stick...

See More

Key Turning Points

3rd Resistance Point 1.0763
2nd Resistance Point 1.0331
1st Resistance Point 0.9663
Last Price 0.8994
1st Support Level 0.8563
2nd Support Level 0.8131
3rd Support Level 0.7463

See More

52-Week High 1.5400
Fibonacci 61.8% 1.1542
Fibonacci 50% 1.0350
Fibonacci 38.2% 0.9158
Last Price 0.8994
52-Week Low 0.5300

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar